Seliciclib Terminated Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00372073Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer